Platinum Nanoparticles as Modulators of Idarubicin Activity: A Physicochemical and In Vitro Biological Study
Marcin Zakrzewski, Patrycja Bełdzińska, Karolina Gackowska, Aliaksandra Yurchak, Marzena Jamrógiewicz, Dariusz Wyrzykowski, Katarzyna Bury, Katarzyna Grzyb, Grzegorz Gołuński, Jacek Piosik · 2026
Read Platinum Nanoparticles as Modulators of Idarubicin Activity: A Physicochemical and In Vitro Biological Study by Marcin Zakrzewski, Patrycja Bełdzińska, Karolina Gackowska, Aliaksandra Yurchak, Marzena Jamrógiewicz, Dariusz Wyrzykowski, Katarzyna Bury, Katarzyna Grzyb, Grzegorz Gołuński, Jacek Piosik (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13517054.txt.
Description
A peer-reviewed research article from Europe PMC (2026). Background/Objectives: Cancer remains one of the leading causes of death worldwide. Although chemotherapy is widely used, it is associated with severe side effects, including myelosuppression and systemic toxicity. Nanoparticles have emerged as promising candidates for modulating drug activity. In this study, we investigated whether platinum nanoparticles (PtNPs) of various sizes interact with idarubicin (IDA), an anthracycline anticancer drug used primarily to treat acute leukaemia.
Catalog record
| CREATOR | Marcin Zakrzewski, Patrycja Bełdzińska, Karolina Gackowska, Aliaksandra Yurchak, Marzena Jamrógiewicz, Dariusz Wyrzykowski, Katarzyna Bury, Katarzyna Grzyb, Grzegorz Gołuński, Jacek Piosik |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |